
Evolent Health EVH
$ 3.35
-5.77%
Quarterly report 2025-Q2
added 08-11-2025
Evolent Health ROE Ratio 2011-2026 | EVH
Annual ROE Ratio Evolent Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.23 | -5.42 | -53.95 | -32.5 | -4.43 | -5.8 | -17.51 | 35.58 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.58 | -53.95 | -10.78 |
Quarterly ROE Ratio Evolent Health
| 2025-Q2 | 2024-Q2 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.13 | -1.66 | -2.69 | -1.5 | -2.32 | -3.84 | -5.32 | -6.03 | -7.58 | -11.46 | -42.82 | -50.53 | -69.65 | -66.39 | -36.97 | -32.74 | -12.72 | -11.04 | -8.48 | -4.6 | -4.45 | -4.61 | -5.41 | -6.0 | -7.18 | -7.53 | -7.05 | -22.74 | -20.89 | -21.14 | 35.48 | 51.2 | 568.65 | 1790.11 | 2954.3 | 2956.04 | 2439.23 | 1219.61 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2956.04 | -69.65 | 303.29 |
ROE Ratio of other stocks in the Health information services industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
American Well Corporation
AMWL
|
-40.62 | $ 5.67 | 3.85 % | $ 91 M | ||
|
Accolade
ACCD
|
-12.96 | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
15.1 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
-24.54 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-3.57 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
-50.2 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
7.4 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
3.19 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
-19.58 | - | - | $ 102 M | ||
|
1Life Healthcare
ONEM
|
-14.73 | - | - | $ 3.37 B | ||
|
Akerna Corp.
KERN
|
303.85 | - | - | $ 161 M | ||
|
HealthStream
HSTM
|
5.57 | $ 22.01 | -0.2 % | $ 669 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
9.55 | - | -10.39 % | $ 886 M | ||
|
HealthEquity
HQY
|
1.3 | $ 80.56 | -0.73 % | $ 6.89 B | ||
|
MTBC
MTBC
|
15.77 | - | -0.58 % | $ 51.7 M | ||
|
Change Healthcare
CHNG
|
-1.75 | - | - | $ 9.03 B | ||
|
So-Young International
SY
|
-32.05 | $ 2.91 | 1.04 % | $ 231 M | ||
|
Omnicell
OMCL
|
1.01 | $ 41.99 | 1.11 % | $ 1.93 B | ||
|
10x Genomics
TXG
|
-34.42 | $ 21.62 | -3.35 % | $ 2.53 B | ||
|
GoodRx Holdings
GDRX
|
2.26 | $ 2.28 | 4.59 % | $ 879 M | ||
|
Veeva Systems
VEEV
|
11.32 | $ 194.25 | 3.06 % | $ 31.2 B | ||
|
Health Catalyst
HCAT
|
-19.03 | $ 1.92 | -1.54 % | $ 116 M | ||
|
Progyny
PGNY
|
2.5 | $ 17.69 | -0.56 % | $ 1.52 B | ||
|
Premier
PINC
|
1.17 | - | - | $ 2.33 B | ||
|
Teladoc Health
TDOC
|
-14.46 | $ 5.12 | -0.29 % | $ 902 M | ||
|
R1 RCM
RCM
|
28.04 | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
30.07 | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
-13.88 | $ 7.42 | -5.72 % | $ 127 M | ||
|
NextGen Healthcare
NXGN
|
2.2 | - | - | $ 1.6 B | ||
|
Phreesia
PHR
|
-54.44 | $ 12.03 | -4.75 % | $ 656 M | ||
|
SCWorx Corp.
WORX
|
-25.31 | $ 0.13 | -6.18 % | $ 190 K | ||
|
Schrödinger
SDGR
|
-28.37 | $ 12.93 | -1.49 % | $ 950 M | ||
|
Zhongchao
ZCMD
|
-3.09 | $ 1.71 | 2.1 % | $ 8.9 M | ||
|
Signify Health
SGFY
|
-70.29 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-82.75 | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
258.65 | - | - | $ 255 M |